Cabaletta Bio Cash and Cash Equivalents 2011-2026 | CABA

Annual Cash and Cash Equivalents Cabaletta Bio

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
193 M	81.6 M	122 M	101 M	136 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
193 M	81.6 M	127 M

Quarterly Cash and Cash Equivalents Cabaletta Bio

2025-Q3	2025-Q2	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
60.2 M	146 M	164 M	171 M	179 M	175 M	193 M	116 M	128 M	93.8 M	81.6 M	61.2 M	47.2 M	59.6 M	122 M	118 M	99.5 M	97.3 M	101 M	101 M	101 M	101 M	136 M	136 M	136 M	136 M	33 M	33 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
193 M	33 M	112 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	2.33 M	-	2.71 %	$ 14 M	USA
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
ANI Pharmaceuticals ANIP	145 M	$ 80.97	0.78 %	$ 1.56 B	USA
Adaptimmune Therapeutics plc ADAP	144 M	-	-15.15 %	$ 60.3 M	Britain
Adverum Biotechnologies ADVM	60.7 M	-	-	$ 86.2 M	USA
Amarin Corporation plc AMRN	199 M	$ 14.8	0.34 %	$ 6.03 B	Irlanda
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Aptorum Group Limited APM	3.5 M	$ 0.87	6.7 %	$ 4.74 M	China
Adagene ADAG	75.2 M	$ 2.63	-1.5 %	$ 148 M	China
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
AlloVir ALVR	118 M	-	4.14 %	$ 49.1 M	USA
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Alterity Therapeutics Limited ATHE	34.8 M	$ 3.55	-0.56 %	$ 8.54 B	Australia
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
Aeglea BioTherapeutics AGLE	89.4 M	-	-	$ 1.01 B	USA
Aptose Biosciences APTO	6.15 M	-	-45.71 %	$ 1.2 M	Canada
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
Ascendis Pharma A/S ASND	560 M	$ 221.53	-0.23 %	$ 5 B	Danmark
Allena Pharmaceuticals ALNA	30 M	-	3.16 %	$ 1.9 M	USA
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
BioNTech SE BNTX	9.76 B	$ 112.43	1.89 %	$ 27.2 B	Germany
Arena Pharmaceuticals ARNA	220 M	-	-6.81 %	$ 3.04 B	USA
Aridis Pharmaceuticals ARDS	4.88 M	-	17.91 %	$ 11.1 M	USA
Burford Capital Limited BUR	322 M	$ 9.29	3.45 %	$ 1.45 B	Britain
Aeterna Zentaris AEZS	16.4 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	345 K	-	-10.17 %	$ 12.2 K	USA
Athira Pharma ATHA	48.4 M	-	-	$ 269 M	USA
Athersys ATHX	37.4 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Avenue Therapeutics ATXI	2.59 M	-	-52.27 %	$ 4.45 M	USA
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 4.55	6.29 %	$ 9.9 B	Israel
Autolus Therapeutics plc AUTL	240 M	$ 1.46	-0.1 %	$ 373 M	Britain
Amneal Pharmaceuticals AMRX	111 M	$ 14.52	-	$ 4.49 B	USA
Codexis CDXS	19.3 M	$ 1.29	0.01 %	$ 94.7 M	USA
AIkido Pharma AIKI	4.08 M	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	98 M	-	1083.1 %	$ 745 M	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
Alpine Immune Sciences ALPN	13.4 M	-	-	$ 2.17 B	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel